Camp4 Therapeutics (CAMP) Profit After Tax (2023 - 2026)
Camp4 Therapeutics recorded quarterly Profit After Tax of -$18.3 million in Q1 2026, up 54.51% quarter-over-quarter from -$40.3 million in Q4 2025, and down 47.44% year-over-year from -$34.9 million in Q1 2025.
Camp4 Therapeutics' Profit After Tax history runs 4 years deep, the most recent figure standing at -$18.3 million for Q1 2026.
- In Q1 2026, Profit After Tax fell 47.44% year-over-year to -$18.3 million; the TTM figure through Mar 2026 stood at -$86.3 million (down 66.74% YoY), while the FY2025 annual figure was -$80.4 million, down 55.24% from the prior year.
- Profit After Tax came in at -$18.3 million for Q1 2026 at Camp4 Therapeutics, up from -$40.3 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$11.7 million in Q3 2023 to a low of -$40.3 million in Q4 2025.
- A 4-year average of -$15.9 million and a median of -$13.0 million in 2023 frame the typical range for Profit After Tax.
- On a YoY basis, Profit After Tax climbed as much as 0.18% in 2025 and fell as far as 203.49% in 2025.
- Camp4 Therapeutics' Profit After Tax stood at -$13.0 million in 2023, then decreased by 2.22% to -$13.3 million in 2024, then sank by 203.49% to -$40.3 million in 2025, then surged by 54.51% to -$18.3 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered -$18.3 million, -$40.3 million, and -$15.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Camp4 Therapeutics | 245.89 Mn | 245.89 Mn | - | -18.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.33 Mn |
| Dec 31, 2025 | -40.30 Mn |
| Sep 30, 2025 | -15.10 Mn |
| Jun 30, 2025 | -12.59 Mn |
| Mar 31, 2025 | -12.43 Mn |
| Dec 31, 2024 | -13.28 Mn |
| Sep 30, 2024 | -13.48 Mn |
| Jun 30, 2024 | -12.57 Mn |
| Mar 31, 2024 | -12.46 Mn |
| Dec 31, 2023 | -12.99 Mn |
| Sep 30, 2023 | -11.70 Mn |